Dianthus Therapeutics, Inc. /DE/ (DNTH)

SEC filing

Dianthus Therapeutics, Inc. /DE/

DNTH · CIK 1690585

4 · Dec 5, 2025 · Savitz Ryan sold 20K shares at $45.18/share ($903.6K); exercised options for 20K shares

Savitz Ryan sold 20K shares at $45.18/share ($903.6K); exercised options for 20K shares

xslF345X05/ownership.xml

xslF345X05/ownership.xmlSEC.gov

Graphics and non-inline formats (not embedded below).